Article info
PDFLeading article
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
- Correspondence to Professor Laurent Beaugerie, Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine 184 rue du faubourg Saint-Antoine, 75571 Paris CEDEX 12, France; laurent.beaugerie{at}sat.aphp.fr
Citation
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
Publication history
- Revised October 31, 2011
- Accepted November 12, 2011
- First published December 9, 2011.
Online issue publication
April 18, 2016
Article Versions
- You are viewing the most recent version of this article.
- Previous version (18 April 2016).
- latest version (26 October 2017).
- latest version (26 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.